Baker Avenue Asset Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$328K Buy
13,344
+1,552
+13% +$35.9K 0.01% 656
2026
Q1
$282K Sell
11,792
-1,458
-11% -$35.6K 0.01% 623
2025
Q4
$300K Buy
+13,250
New +$288K 0.01% 504
2023
Q4
Sell
-27
Closed -$303 685
2023
Q3
$303 Sell
27
-75
-74% -$871 ﹤0.01% 1562
2023
Q2
$1.03K Sell
102
-57
-36% -$529 ﹤0.01% 1170
2023
Q1
$1.5K Buy
159
+125
+368% +$1.48K ﹤0.01% 1062
2022
Q4
$415 Buy
+34
New +$424 ﹤0.01% 1419

Other funds holding ELAN

Baker Avenue Asset Management's ELAN Position: Q2 2026 in Review

Baker Avenue Asset Management increased its Elanco Animal Health (ELAN) stake by 13% in Q2 2026, buying an estimated $35.9K and bringing the position to 13,344 shares worth $328K. The position accounts for 0.01% of the portfolio, ranked #656.

Baker Avenue Asset Management first reported a position in ELAN in Q4 2022 and has held it in 7 quarters since. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Baker Avenue Asset Management held 13,344 shares of Elanco Animal Health worth $328K as of Q2 2026.
  • Baker Avenue Asset Management bought 1,552 Elanco Animal Health shares in Q2 2026, an estimated $35.9K.
  • Elanco Animal Health made up 0.01% of Baker Avenue Asset Management's portfolio in Q2 2026, its #656 holding.
  • Baker Avenue Asset Management first reported a position in Elanco Animal Health in Q4 2022 and has held it in 7 quarters since.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.